Clinuvel Pharmaceuticals Limited (ASX:CUV)
Australia · Delayed Price · Currency is AUD 11.73
-0.06 (-0.51%)
At close: Feb 5, 2026
Clinuvel Pharmaceuticals Market Cap
Clinuvel Pharmaceuticals has a market cap or net worth of 588.85 million as of February 5, 2026. Its market cap has increased by 0.68% in one year.
Market Cap
588.85M
Enterprise Value
365.28M
Revenue
95.02M
Ranking
n/a
PE Ratio
16.34
Stock Price
11.73
Market Cap Chart
Since February 13, 2001, Clinuvel Pharmaceuticals's market cap has increased from 5.23M to 588.85M, an increase of 11,168.51%. That is a compound annual growth rate of 20.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 4, 2026 | 591.87M | -5.38% |
| Dec 31, 2025 | 625.50M | 3.84% |
| Dec 31, 2024 | 602.36M | -24.90% |
| Dec 29, 2023 | 802.04M | -25.09% |
| Dec 30, 2022 | 1.07B | -20.36% |
| Dec 31, 2021 | 1.34B | 21.91% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Clarity Pharmaceuticals | 1.15B |
| PYC Therapeutics | 933.22M |
| Opthea | 738.77M |
| Immutep | 596.86M |
| Racura Oncology | 401.10M |
| Dimerix | 306.20M |
| Orthocell | 257.74M |
| Tetratherix | 202.05M |